Current clinical options for diagnosis and treatment of recurrent spontaneous abortion

American Journal of Reproductive Immunology

Volumn 38, Issue 2, 1997, Pages 57-74

  Coulam, Carolyn B ^a   Clark, David A ^a   Beer, Alan E ^a   Kutteh, William H ^a   Silver, Robert ^a   Kwak, Joanne ^a   Stephenson, Mary ^a  

^a Chicago Center for Human Reproduction   (United States)

Author keywords

Antiphospholipid antibodies; Aspirin; Heparin immunotherapy; Natural killer cells; Prednisone; Recurrent spontaneous abortion

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PREDNISONE;

FEMALE; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION;

EID: 0030798817     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00277.x     Document Type: Review

References (187)

1. Coulam CB: Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 26:23-27.
2. Kutteh WH, Pasquarette M: Recurrent pregnancy loss. Adv Obstet Gynecol 1995; 2:147-177.
3. Regan L: Recurrent miscarriage. Br Med J 1991; 302:543- 544.
4. Hansen JP: Older maternal age and pregnancy outcome: A review of the literature. Obstet Gynecol Surv 1986; 41:726-742.
5. Clark DA, Daya S, Coulam CB, Gunby J: Implications of abnormal human trophoblast karyotype for the evidence- based approach to the understanding, investigation and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:495-498.
6. Coulam CB, Stephenson MD, Stern JJ, Clark DA. Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.
7. Warburton D, Kline J, Stein Z, Hutzler M, Chin A, Hassold T: Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with karyotyped spontaneous abortions. Am J Hum Genet 1987; 41:465-468.
8. Coulam CB: Association between infertility and spontaneous abortion. Am J Reprod Immunol 1992; 27:128-129.
9. Jansen RPS: Spontaneous abortion incidence in the treatment of infertility. Am J Obstet Gynecol 1982; 143:451-473.
10. Peters AJ, Coulam CB, Critser ES: Association between recurrent spontaneous abortion and subfertility. Am J Reprod Immunol 1990; 25:87-89.
11. Coulam CB: Implantation failure and immunotherapy. Hum Reprod 1995; 10:1338-1340.
12. Steer C, Campbell S, Davies M, Mason B, Collins W: Spontaneous abortion rates after natural and assisted conception. Br Med J 1989; 299:1317-1318.
13. Alarcon-Segouia D, Deleze M, Aria CV, Sanchez-Guerro J, Gomez-Pacheo R, Cabiedas J, Fernandez L: Antiphospholipid antibodies and the antiphospholipid antibody syndrome in systemic lupus erythematosus. Medicine 1989; 68:353-365.
14. Kutteh WH, Lyda E, Abraham S, Wacholtz M: Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 1993; 60:449-455.
15. Coulam CB: Unexplained recurrent pregnancy loss: Epilogue. Clin Obstet Gynecol 1986; 29:999-1004.
16. De Brackeller M, Dao TN: Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod 1990; 5:519-528.
17. Clifford K, Rai R, Watson H, Regan L: An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9:1328-1332.
18. Stephanson MD: Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996; 66:24-29.
19. Ohno M, Meada T, Matsumoku A: A cytogenetic study of spontaneous abortions with direct analysis of chorionic villi. Obstet Gynecol 1991; 77:394-398.
20. Stern JJ, Dorzman A, Gutierez-Najar AJ, Cerrillo M, Coulam CB: Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65:250-253.
21. Drugan A, Koppitch FC, Williams JC, Johnson MP, Moghissi KS, Evans MI: Prenatal genetic diagnosis following recurrent early pregnancy loss. Obstet Gynecol 1990; 75:381-384.
22. Jin K, Ho HN, Speed, Gill TJ III: Reproductive failure and the major histocompatibility complex. Am J Genet 1995; 56:1456-1467.
23. Ho HN, Gill TJ III, Nsieh RP, Hsieh HJ, Lee TY: Sharing of human leukocyte antigens in primary and secondary recurrent spontaneous abortions. Am J Obstet Gynecol 1990; 163:178-188.
24. Gill TJ: Influence of MHC and MHC-linked genes on reproduction. Am J Hum Genet 1992; 50:1-5.
25. Ho HN, Yang YS, Hsieh RP, Lin HR, Chen SU, Chen HF, Huang SC, Lee TY, Gill TJ III: Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer. Am J Obstet Gynecol 1994; 170:63-71.
26. Ober C, Elias S, Kostyu DD, Hauch WW: Decreased fecundability in Hutterite couples sharing HLA-DR. Am J Hum Genet 1992; 50:6-14.
27. Beer AE, Kwak JYH, Gilman-Sacks A, Beaman KD: New horizons in the evaluation and treatment of recur- rent pregnancy loss. In Immunobiology of Reproduction, JS Hunt (ed). New York, Serono Symposia, USA, 1994, pp 316-334.
28. Dizon-Townson D, Nelson L, Scott JR, Branch DW, Ward K: Human leukocyte antigen DQd sharing is not increased in couples with recurrent miscarriage. Am J Reprod Immunol 1995; 34:209-212.
29. Ober C, Steck T, van der Ven CB, Messer L, Kwak J, Beaman K, Beer A: MHC class II compatibility in aborted fetuses and term infants of couples with recurrent spontaneous abortion. J Reprod Immunol 1993; 25:195-207.
30. Treffers PE: Uterine causes of early pregnancy failure; a critical evaluation. In Early Pregnancy Failure, HJ Huisyis, T Lind eds). Edinburgh, Churchill Livingston, 1990, pp 114-147.
31. Ludmir J, Samuels P, Brooks S, Mennuti MT: Pregnancy outcome of patients with uncorrected uterine anomalies managed in a high-risk obstetric setting. Obstet Gynecol 1990; 75:906-910.
32. Simon C, Martinez L, Pardo F, Tarajada M, Pelicer A: Mullerian defects in women with normal reproductive outcome. Fertil Steril 1991:56; 1192-1193.
33. Kirk EP, Chuong CJ, Coulam CB, Williams TJ: Pregnancy after metroplasty for uterine anomalies. Fertil Steril 1993; 59:1164-1168.
34. Bennett MJ: Congenital abnormalities of the fundus. In Spontaneous and Recurrent Abortion, MJ Bennett, DK Edmonds (eds). Oxford, Blackwell Scientific Publications, 1987, pp 109-129.
35. Charles D, Larsen B: Spontaneous abortion as a result of infection. In Early Pregnancy Failure, HJ Huisjes, T Lind (eds). Edinburgh, Churchill Livingston, 1990, pp 161-176.
36. Simpson JL, Mills JL, Kim H, Holmes LB, Lee J, Metzer B, Knapp R, Jovanovic-Peterson L, Aarons J, Conley M: Infectious process: an infrequent cause of first trimester spontaneous abortions. Hum Reprod 1996; 11:668-672.
37. Fritz MA: Inadequate luteal function and recurrent abortion. Semin Reprod Endocrinol 1988; 6:129-143.
38. Coulam CB, Stern JJ: Endocrine factors associated with recurrent spontaneous abortion. Clin Obstet Gynecol 1994; 37:730-744.
39. Baird DD, Weinberg CR, Wilcox AJ, McConnaughey DR, Musey PI, Collins DC: Hormonal profiles of natural conception cycles ending in unrecognized pregnancy loss. J Clin Endocrinol Metab 1991; 72:793-800.
40. Goldstein P, Berreir J, Rosen S, Sacks HS, Chalmers IC: A metaanalysis of randomized control trials of pregestational agents in pregnancy. Br J Obstet Gynecol 1989; 96:265-274.
41. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319:1617-1623.
42. Gilnoer D, Sato MF, Bourdaux P, et al.: Pregnancy in patients with mild thyroid abnormalities: Maternal and neonatal repercussion. J Clin Endocrinol Metab 1991; 73:421-427.
43. Stagnaro-Green A, Roman SH, Cabin RH, Harvey E, Alvarez-Marfany M, Davies TF: Detection of at risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264:1422-1425.
44. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N: Antithyroid antibodies and the association in nonorgan specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 1993; 168:837-841.
45. Shelton AJ, Harger JH, Dorman JS, Kuller LH, La Porte RE, Gill TJ III: Association between familial autoimmune disease and recurrent spontaneous familial autoimmune disease and recurrent spontaneous abortions. Am J Reprod Immunol 1994; 32:82-87.
46. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, Beard DW, Franks S: Recurrent early miscarriage and polycystic ovaries. Br Med J 1988; 297: 1027-1028.
47. Hasegawa I, Takakuwa K, Tanaka K: The roles of oligomenorrhea and fetal chromosomal abnormalities in spontaneous abortions. Hum Reprod 1996; 1:2304-2305.
48. Balen AH, Ian SL, MacDougal J, Jacobs HS: Miscarriage rates following in vitro fertilization are increased in women with polycystic ovaries are not reduced by pituitary desensitization with buserelin. Hum Reprod 1993; 8:959-964.
49. Clifford K, Rai R, Watson H, Franks S, Regan L: Does suppressing luteinizing hormone secretion reduce the miscarriage rate: Results of a randomized trial, Br Med J 1996; 312:1508-1511.
50. Cowchock FS, Smith JB, Gocial B: Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986; 155:1002-1010.
51. Barbui T, Radici E, Cortelazzo S, Rossi E, Galli M, Finazzi G, Parazzini F: Antiphospholipid antibodies in early repeated abortions. A case-controlled study. Fertil Steril 1988; 50:589-592.
52. Kwak JYH, Gilma-Sacks A, Beaman KD, Beer AE: Antibodies in women with primary recurrent spontaneous abortion of unknown etiology. J Reprod Immunol 1992; 22:15-31.
53. Gleicher N, El-Roiey A, Confino E, et al.: Reproductive failure because of autoantibodies. Unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989; 160:1376-1385.
54. Kaider BD, Purvis MT, Roussev RG, Coulam CB: Prevalence of abnormal immunologic test results in women with reproductive failure. Am J Reprod Immunol 1996; 35:45.
55. Roussev FG, Kaider BD, Price DE, Coulam CB: Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol 1996; 35:415-420.
56. Rote NS: Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1996; 35:393-401.
57. Hadi HA, Treadwell EL. Lupus anticoagulant and anticardiolipin antibodies in pregnancy: A review II. Diagnosis and management. Obstet Gynecol Surv 1990; 45:786-791.
58. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991; 77:854-857.
59. Parazzini F, Acaia B, Faden D, Lovaotti M, Marelli G, Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991; 77:854-857.
60. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991; 34:1231-1235.
61. Bahar AM, Kwak JYH, Beer AE, Kim IE, Nelson LA, Beaman KD, Gilman-Sacho A: Antibodies to phospholipids and nuclear antigens in non-pregnant women with unexplained spontaneous recurrent abortion. J Reprod Immunol, 1993; 24:213-222.
62. Ruiz JE, Cubillos J, Mendoza JC, Espinel FJ, Kwak JYH, Beer AE: Antibodies to phospholipid and nuclear antigens in nonpregnant and pregnant Columbian women with recurrent spontaneous abortions. J Reprod Immunol 1995; 28:41-57.
63. Yetman DL, Kutteh WH: Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996; 66:540-546.
64. Purvis MT, Kaider BD, Rousev RG, Coulam CB: Antinuclear antibody prevalence in patients with IVF failure. Am J Reprod Immunol 1996; 35:463.
65. Sessions A, Horowitz AF: Differentiation related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells. Biochim Biophys Acta 1983; 728:103-111.
66. DeWolf F, Carreras LO, Moerman P, Vermylen P, Van Assche A, Renaer M: Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142:829-834.
67. Out HJ, Kooijman CD, Bruinse HW, Derksen RHWM: Histo-pathological findings from patients with intrauterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynecol 1991; 41:179-186.
68. Braulke I, Pruggmayer M, Mellon P, Hinney B, Kostering H, Gunther E: Factor XII (Hageman) deficiency in women with habitual abortion: new subpopulation of recurrent aborters? Fertil Steril 1993; 59:98-101.
69. Hughes GRV, Harris EN, Gharavi AE: The anticardiolipin syndrome. J Rheumatol 1986; 13:485-489.
70. Harris EN: Syndrome of the black swan. Br J Rheumatol 1986; 26:324-326.
71. Asherson RA, Khamashta MA, Ordi-Ros J, et al.: The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine 1989; 68:366-374.
72. Alarcon-Segovia D, Perex-Vasquez ME, Villa AR, Drenkard C, Cabiedes J: Preliminary classification criteria for the antiphospholipid syndrome lupus erythematos us. Semin Arthritis Rheum 1992; 21:275-286.
73. Branch DW, Scott JR, Kochenour NK, Hershgold E: Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313:1322-1326.
74. Lockshin MD, Druzin ML, Goei S, et al.: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313:152-156.
75. Harris EN, Chan JK, Asherson RA, et al.: Thrombosis, recurrent fetal losses and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146:2153-2156.
76. Harris EN: A reassessment of the antiphospholipid syndrome. J Rheumatol 1990; 17:733-735.
77. Placeman AM, Silver RK, MacGregor SN, Socol ML: Interlaboratory variation in antiphospholipid antibody testing, Am J Obstet Gynecol 1992; 166:1780-1787.
78. Coulam CB, McIntyre JA, Wagenknecht, Rote N: Interlaboratory inconsistencies in detection of anticardiolipin antibodies (letter). Lancet 1990; 335:865.
79. Stern JJ, Coulam CB: When to start treatment after positive antiphospholipid antibody. J Immunol 1993; 150:1361.
80. 2 glycoprotein 1 in 500 women with recurrent miscarriage: Results of a comprehensive screening approach. Hum Reprod 1995; 10:2001-2005.
81. Silver RM, Porter TF, Van Leeuwan I, Jeng G, Scott JR, Branch DW: Anticardiolipin antibodies: Clinical consequences of "low titers." Obstet Gynecol 1996; 87:494-500.
82. Croy BA, Gambel P, Rossant J, Wegmann TG: Characterization of murine decidual natural killer (NK) cells and their relevance to the success of pregnancy. Cell Immunol 1985; 93:315-326.
83. Starkey PM, Sargent LL, Redman CWG: Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 1988; 65:129-134.
84. Michel M, Underwood J, Clark DA, Mowbray J, Beard RW: Histologic and immunologic study of uterine biopsy tissue of incipiently aborting women. Am J obstet Gynecol 1989; 161:409-414.
85. Lea RG, Underwood J, Flanders KC, Hirte H, Branwatt D, Michel M, Daya S, Harley C, Mowbray JF, Clark DA: A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor beta 2-producing suppressor cells in decidua near the placental attachment site. Am J Reprod Immunol 1995; 34:52-64.
86. 2-related immunosuppressive factors. Hum Reprod 1994; 9:2270-2277.
87. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B and NK cells in patients with recurrent spontaneous abortion. J Immunol 1996; 156:4027-4034.
88. Clark DA, Drake B, Head JR, Stedronska-Clark J, Banwatt D: Decidua-associated suppressor activity and viability of individual implantation sites of allopregnant mice. J Reprod Immunol 1990; 17:253-264.
89. Roussev RG, Higgins NG, McIntyre JA: Phenotypic characterization of normal human placental mononuclear cells. J Reprod Immunol 1993; 25:15-29.
90. Arck PC, Ferrick DA, Steele-Norwood D, Croitoru K, Clark DA: Murine T cell determination of pregnancy outcome. I. Effects of strain, αβ T cell receptor and γδ T cell subsets. Am J Reprod Immunol 1997:in press
91. Clark DA, Lea RG, Flanders KC, Brawath D, Chaoset G: Role of a unique species of TGF-β in preventing rejection of the conceptus during pregnancy. In Congress of Immunology VIII, G Gergely, et al. (eds). Budapest, Springer- Verlag, 1991, pp 841-884.
92. Makida R, Minami M, Takamizawa M, Juji T, Fujii T, Mizuno M: Natural killer cell activity and immunotherapy for recurrent spontaneous abortion. Lancet 1991; 2:579-580.
93. Yokoyama M, Sano M, Sonoda K, Nozaki M, Nakamura GI, Nakano H: Cytotoxic cells directed against placental cells detected in human habitual abortions by an in vitro terminal labelling assay. Am J Reprod Immunol 1994; 31:197-204.
94. Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
95. Hill JA, Polgar K, Harlow BL, Anderson DJ: Evidence of embryo- and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1992; 166:1044-1052.
96. Hill JA, Haimovici F, Anderson DJ: Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 1987; 139:2250-2254.
97. Kwak JYH, Kwak FMY, Ainbinder SW, Ruiz AM, Beer AE: Elevated peripheral blood natural killer cells are effectively suppressed by immunoglobulin G infusions in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35:363-369.
98. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptual natural killer cell activity as a predictor of miscarriage. Lancet 1995; 345:1340-1342.
99. Chavez DJ, McIntyre JA: Sera from women with histories of repeated pregnancy losses cause abnormalities in mouse peri-implantation blastocyst. J Reprod Immunol 1984; 6:273-281.
100. Oksenberg JR, Brautbar C: In vitro suppression of murine blastocysts growth by sera from women with reproductive disorders. Am J Reprod Immunol 1986; 11:118-124.
101. Zigril M, Fein A, Carp H, Toder V: Immuno-potentiation reserves the embryotoxic effect a serum from women with pregnancy loss. Fertil Steril 1991; 56:653-659.
102. Eckler JL, Laufer MR, Hill JA: Measurement of embryotoxic factors is predictive of pregnancy outcome in women with a history of recurrent abortion. Obstet Gynecol 1993; 81:84-87.
103. Sargent IL, Dokras A: Embryotoxicity as a marker for recurrent pregnancy loss. Am J Reprod Immunol 1996; 35:383-387.
104. Roussev RG, Stern JJ, Thorsell L, Thomason EJ, Coulam CB: Validation of an embryotoxicity assay. Am J Reprod Immunol 1994; 32:1-5.
105. Coulam CB: Immunologic tests in the evaluation of reproductive disorders: A critical review. Am J Obstet Gynecol 1992; 167:1844-1851.
106. Newland AC: The use and mechanism of action of intravenous immunoglobulin: An update. Br J Haematol 1989; 72:301-305.
107. McIntyre JA, Faulk WP, Nicholas-Johnson VR, Taylor CG: Immunological testing and immunotherapy in recurrent spontaneous abortion. Obstet Gynecol 1986; 67:169-174.
108. Mowbray JF: Autoantibodies, alloantibodies and reproductive success. In Current Opinion in Immunology, I Roitt (ed). London, Alden Press, 1989, pp 761-764.
109. Toder V, Strassburger D, Carp H: Immunopotentiation and pregnancy loss. J Reprod Fertil 1989; 37:79-83.
110. Rocklin RA, Kitzmiller JL, Carpenter CB, Garvey MR, David JR: Maternal-fetal relation: Absence of an immunologic blocking factor from serum of women with chronic abortions. N Engl J Med 1976; 295:1209-1214.
111. Rocklin RF, Kitzmiller JL, Garvey MR: Maternal-fetal relations. II. Further characterization of an immunologic blocking factor that develops during pregnancy. Clin Immunol Pathol 1982; 22:305-309.
112. Roger JC: Lack of a requirement for a maternal humoral immune response to establish or maintain successful allogeneic pregnancy. Transplant 1985; 40:372-376.
113. Gilman-Sach A, Luo SP, Beer AE, Beaman KD: Analysis of antilymphocyte antibodies by flow cytometry or microlymphocytotoxicity in women with recurrent spontaneous abortions immunized with paternal leukocytes. J Clin Lab Immunol 1989; 30:53-59.
114. Stephenson MD, Wu V, Mackinnon M, Sadoivay J, Keown P: Standardization of flow cytometric crossmatch (FCXM) for investigate of unexplained habitual abortion. Am J Reprod Immunol 1995; 33:1-9.
115. Coulam CB, Clark DA, Collins JA, et al. (The Recurrent Miscarriage Immunotherapy Trialist Group): Worldwide collaborative observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32:55-72.
116. Schagen van Leeuwen JH, Christians GCML, Hoogenraad TU: Recurrent abortion and the diagnosis of Wilson disease. Obstet Gynecol 1991; 78:547-549.
117. Wouters MGAJ, Broers GHJ, Blom HJ, Trijbels FJM, Thomas CHMG, Borm GF, Steegers-Theunissen RPM, Eskes TKAB: Hyperhomo-cysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993; 60:820-825.
118. Sbracia M, Grasso JA, Scarpillini F: A prospective controlled trial of aspirin versus placebo for treatment of women with recurrent spontaneous abortion associated with antiphospholipid antibodies. Am J Reprod Immunol 1994; 31:242.
119. Rai R, Cohen H, Dave M, Regan L: Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314:253-257.
120. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1-6.
121. Silver RK, MacGregar SN, Small JS, et al.: Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin-antibody positive obstetric patients. Am J Obstet Gynecol 1993; 169:1411-1417.
122. Rote NS: Pregnancy associated immunologic disorders. Curr Opin Immunol 1989; 1:1165-1172.
123. Kutteh WH, Ermel LD: A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996; 35:402-407.
124. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989; 20:52-67.
125. Dekker GA, Sibai BM: Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms and clinical trials. Am J Obstet Gynecol 1993; 168:214-217.
126. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L: Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 155:1318-1323.
127. McIntyre JA, Taylor CG, Torry DS, Wagenknecht DR, Wilson J, Faulk WP: Heparin and pregnancy in women with a history of repeated miscarriages. Hemostasis 1993; 23:202-211.
128. Ermel LD, Marshburn PB, Kutteh WH: Interaction of heparin with antiphospholipid antibodies (APA) form the sera of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995; 33:14-20.
129. Kwak JYH, Gilman-Sachs A, Beaman KD, Beer AE: Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: preconception versus postconception treatment. Am J Obstet Gynecol 1992; 166:1787-1795.
130. Babcock RB, Dumper CW, Scharfman WB: Heparin-induced immunothrombocytopenia. N Engl J Med 1976; 295:237-241.
131. Dahlman T, Sjoberg HE, Ringertz H: Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol 1994; 170:1315-1320.
132. Hasegawa I, Takakiwa K, Goto S, Yamada K, Sekizuka N, Kanazawa K, Tanaka K: Effectiveness of prednisone/aspirin therapy for recurrent aborters with antiphospholipid antibody. Hum Reprod 1992; 7:203-207.
133. Ramsdon CF, Farquharson RG: A woman with twelve first trimester losses in whom lupus anticoagulant was detected and treated with steroids, sandoglobulin and heparin. Clin Exp Rheumatol 1990; 8:221-222.
134. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992; 80:614-620.
135. Lima F, Khamashta MA, Buchanan NMM, Kerslake S, Hunt BJ, Hughes GRV: A prospective study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; xx.
136. Silver RM, Draper ML, Scott JR, Lyon JL, Readong J, Branch DW: Clinical consequence of antiphospholipid antibodies: and historic cohort study. Obstet Gynecol 1994; 83:372-377.
137. Wapner RJ, Cowchock FS, Shapiro SS: Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161:1271-1272.
138. Coulam CB: Immunotherapy for recurrent spontaneous abortion. Early Preg Biol Med 1995; 1:13-26.
139. Christiansen OB, Mathiesen O, Lauristen JG, Grunnet N: Intravenous immunoglobulin treatment of women with multiple miscarriages. Hum Reprod 1992; 7:718-722.
140. Scott JR, Branch DW, Knochenour NK, Ward K: Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988; 159:1055-1056.
141. Bernstein RM, Crawford RJ: Intravenous IgG therapy for anticardiolipin syndrome: a case report. Clin Exp Rheumatol 1988; 6:198-199.
142. Matsuda J, Gohcki K, Kawasugu K, et al.: In vitro lupus anticoagulant neutralizing activity of intravenous immunoglobulin. Thromb Res 1993; 70:109-110.
143. Mowbray JF, Liddel H, Underwood JL, Gibbins C, Reginald PW, Beard RW: Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985; 1:941-949.
144. Gatenby PA, Cameron K, Simes RJ, Adelstein S, Bennett MJ, Jansen RPS, Shearman RP, Stewart GJ, Whittle M, Doran TJ: Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol 1993; 29:88-94.
145. The German RSA/IVIg Group: Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynecol 1994; 101:1072-1077.
146. Coulam CB, Krysa L, Stern JJ, Bustillo M: Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34:333-338.
147. Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, Grunnet N: Placebo-controlled trial for treatment of unexplained secondary recurrent abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 1995; 10:2690-2694.
148. Clark DA, Gunby J, Daya S: The use of allogeneic leukocytes or IVIg for the treatment of patients with recurrent spontaneous abortion. Trans Med Rev 1997:in press.
149. Ho HN, Gill TJ, Hsieh HJ, Jiang JJ, Lee TY, Hsieh CY: Immunotherapy for recurrent spontaneous abortion in a Chinese population. Am J Reprod Immunol 1991; 25:10-15.
150. Cauchi MN, Lim D, Young DE, Kloss M, Pepperell RJ: Treatment of recurrent aborters by immunization with paternal cells-controlled trial. Am J Reprod Immunol 1991; 25:16-17.
151. Daya S, Gunby J. (The Recurrent Miscarriage Immunotherapy Trialist Group): The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32:294-302.
152. Faulk WP, McIntyre JA: Trophoblast survival. Transplantation 1981; 32:1-5.
153. Stern PL, de Wit TFR: The role of MHC class expres- sion in developmental tumors. Semin Cancer Biol 1991; 2:11-15.
154. Parkam P: Review: antigen presentation by class I major histocompatibility complex molecules: A context for thinking about HLA G. Am J Reprod Immunol 1995; 34:10-15.
155. Heyborne K, Fu Y-X, Nelson A, et al.: Recognition of throphoblasts by gamma-delta T cells. J Immunol 1994; 153:2918-2926.
156. Szekeres-Bartho J, Autran B, Debre P, et al.: Immunoregulatory effects of suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989; 122:281-294.
157. Szekeres-Bartho J, Szekeres G, Debre P, et al.: Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990; 125:273-283.
158. Szekeres-Bartho J, Kinsky R, Chaouat G: The effect of progesterone-induced immunologic blocking factor on NK-mediated resorption. Am J Reprod Immunol 1990; 24:105-107.
159. Szekeres-Bartho J, Weill BJ, Mike G, et al.: Progesterone receptors in lymphocytes of live-transplanted and transfused patients. Immunol Lett 1989; 22:259-261.
160. Erard F, Garcia-Sanz JA, Le Gros G: Switch of CDS T cells of noncytolytic CD8- CD4- cells that make TH2 cytokines and help B cells. Science 1993; 260:1802-1805.
161. 2-related immunosuppressive molecules nearing bone marrow depressed natural suppressor cell marker and γδT cell receptor. Biol Reprod:in press.
162. Szekeres-Bartho J, Reznikoff-Etievant MF, Varga P, et al.: Lymphocytic progesterone receptors in normal and pathological human pregnancy. J Reprod Immunol 1989; 16:239-247.
163. Wegmann T, Waters CA, Drell DW, et al.: Pregnant mice are not primed but can be primed to fetal alloantigens. Proc Natl Acad Sci USA 1979; 76:2410-2414.
164. Head JR: Can trophoblasts be killed by cytotoxic cells? In vitro evidence and in vivo possibilities. Am J Reprod Immunol 1989; 20:100-105.
165. Aoki K, Higuchi K, Yagami Y: Suppression of natural killer cell activity by monocytes following immunotherapy for habitual aborters. Am J Reprod Immunol 1995; 33:465.
166. Ruiz JE, Kwak JYH, Baum L, Gilman-Sachs A, Beaman K, Kim YB, Beer AE: Intravenous immunoglobulin inhibits natural killer cell activity in vivo women with recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:370-375.
167. Deifraissy IF, Tchernia G, Laurian Y, et al.: Suppressor cell function after intravenous immunoglobulin treatment in adult chronic idiopathic thrombocytopenic purpura. Br J Haematol 1985; 60:315-322.
168. Clark DA: Controversies in reproductive immunology. Crit Rev Immunol 1991; 11:215-247.
169. Kempf C, Jentsch P, Poirier B, et al.: Virus inactivation during production of intravenous immunoglobulin. Transfusion 1991; 31:423-427.
170. Soto B, Garcia-Bengrechea M, Reistra S, et al.: Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicenter study of 423 pairings. J Intern Med 1994; 236:515-519.
171. Coulam CB, Stephenson M, Stern JJ, Clark DA: Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.
172. Christiansen OB, Mathiesen O, Lauristen JG, Grunnet N: Intravenous immunoglobulin treatment of women with multiple miscarriages. Hum Reprod 1992; 7:718- 722.
173. Rai R, Clifford K, Regan L: The modern preventative treatment of recurrent miscarriage. Br J Obstet Gynecol 1996; 103:106-110.
174. Stray-Peterson B, Stray-Peterson S: Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148:140-146.
175. Vlaanderen W, Treffers PE: Prognosis of subsequent pregnancies after recurrent spontaneous abortion in first trimester. Br Med J. 1987; 295:92-93.
176. Chalmers TC, Celano P, Sacks HS, Smith H Jr: Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983; 309:1358-1361.
177. Clark DA, Coulam CB: Is there an immunological cause of recurrent pregnancy wastage? Adv Obstet Gynecol 1996; 3:321-342.
178. Sher G, Feinaman M, Zouves G, Kuttner G, Maassarani G, Salem R, Matzer W, Chang W, Chong P: High fecundity rates following in vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994; 9:2278-2283.
179. Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in vitro fertilization failure. Hum Reprod 1994; 9:2265-2269.
180. Beer AE, Kwak JYH, Ruiz JE: Immunophenotypic profiles of peripheral blood lymphocytes profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple cycles. Am J Reprod Immunol 1996; 35:376-382.
181. Cowchock FS, Gibas Z, Jackson LG: Chromosome errors as a cause of spontaneous abortion: The relative importance of maternal age and obstetric history, Fertil Steril 1993; 59:1011-1014.
182. Coulam CB, Bustillo M, Soenksen DM, Britten S: Ultrasonographic predictors of implantation after assisted reproduction 1994; 62:1004-1010.
183. Steer CV, Campbell S, Tan SL, et al.: The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992; 57:372-376.
184. Coulam CB, Goodman C: Increased pregnancy rates after IVF/ET with intravenous immunoglobulin treatment in women with elevated circulating CD56+ cells. Early Preg Biol Med 1997:in press.
185. Clark DA, Daya S, Gunby J, Coulam CB: Implications of abnormal human trophoblast karyotype for the evidence- based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:495-498.
186. Kwak JYH, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE: Upregulated expression of CD56+ CD56+/16+ and CD 19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-99.
187. Kwak JYH, Quilty EA, Gilman-Sachs A, Beaman KD, Beer AE: Intravenous immunoglobulin G infusion therapy in women with recurrent spontaneous abortions of immune etiologies. J Reprod Immunol 1995; 28:175-188.